Forget Alexa – true artificial intelligence will be able to understand dementia patients’ needs and offer help accordingly.
Academic rigour, journalistic flair
Articles on Dementia
Displaying 201 - 220 of 397 articles
Technological solutions may help to relieve the burden of care for family, service providers and caregivers working with the elderly.
Artificial intelligence holds great promise for medicine, but safeguards are needed to ensure it does not harm patients.
Alzheimer’s disease is the most common form of dementia. Despite all efforts, no treatments have been found yet. To increase the odds, we need to rethink our approach and try to better understand it.
In dementia sufferers, if autobiographical self-knowledge is lost, feelings of agency – learned as an child – may be the last remaining facet of self, something most studies have ignored.
Many chronic diseases increase our risk of Alzheimer’s disease. This link between our bodies and our brains means certain healthy choices could protect our cognitive function.
Dementia villages and care homes that try and recreate the past are unsustainable.
Ever more Americans are using digital cameras to keep an eye on elderly relatives who live in nursing homes. This surveillance may violate patients’ privacy and demoralize their caretakers.
Our brains create new memories, and forget old ones, by forging and breaking connections between nerve cells. Now researchers can do something similar using a light-sensitive electronic chip.
Some previous research suggests people living in rural areas may be at a higher risk of developing Alzheimer’s disease. But these results tell a different story.
Working as a professional carer is a stressful and high-pressure job. Making sure carers have the right training and support is crucial.
Some carers actually thrive in the face of dementia, here’s why.
Creative arts therapies allow people with dementia to express joy and sadness through painting, dance, music and drama.
Protein tangles have been blamed for causing Alzheimer’s – but drugs that target them keep failing.
Not all drug development needs to start from scratch. Sometimes researchers discover that a drug developed for one disease can be used for another. Here a cancer drug may show promise for dementia.
Nuts are a healthy part of any diet, but can they really make you smarter?
Our ability to smell is a function of the brain, so it makes sense that an impaired sense of smell can point to cognitive decline. The good news is training our noses may be effective.
Antipsychotic drugs are often used to “chemically restrain” aged care residents and control their behaviour. The system needs to change – but lessons from the US tell us it’s not going to be easy.
Many pieces leading to Alzheimer’s disease have been identified. To put the pieces together, one scholar argues that the government should launch a Manhattan Project-scale effort to find a cure.
We were the first to make the connection between P. gingivalis and fully diagnosed Alzheimer’s disease. While evidence of a link is growing, it must be interpreted in context.
Top contributors
-
Associate Professor, Turner Institute for Brain and Mental Health, Monash University
-
Associate professor, University of Sydney
-
Research Fellow in Neuroimmunology, UCL
-
Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University
-
Associate Professor in Cellular Neuroscience, University of Reading
-
Professor in Ageing and Health, University of Sydney
-
Senior Research Fellow, University of Liverpool
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
Editor and Co-Host, The Conversation Weekly Podcast, The Conversation
-
Professor of Psychology in Epidemiology, UCL
-
Professor of Neurology, UCL
-
Professor Emeritus of Molecular Neurobiology at the University of Manchester and a Visiting Professorial Fellow, University of Oxford
-
Post grad student at University of Edinburgh, The University of Edinburgh
-
Investigations Editor, Insights, The Conversation
-
Associate Professor, Neurology, University of Florida
